Novartis in-licenses Antisoma's AS1404

Antisoma (LSE:ASM) granted Novartis (NVS; SWX:NOVN) exclusive, worldwide rights to AS1404 to treat various cancers.

Read the full 154 word article

How to gain access

Continue reading with a
two-week free trial.